Pharmabiz34m
India’s pharma’s 79% CXOs see AI/ML as key drivers of growth: EY Parthenon–OPPI report
EY Parthenon–OPPI report: Our Bureau, Bengaluru Thursday, November 28, 2024, 13:45 Hrs [IST] EY Parthenon (EY-P ...
Pharmabiz19m
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan: Allschwil, Switzerland Thursday, November 28, 2024, 14:00 Hrs [IST] Idorsia ...
Pharmabiz48m
Women in Pharma Roundtable discusses needs and challenges of women in the sector
Women in Pharma Roundtable discusses needs and challenges of women in the sector: Our Bureau, New Delhi Thursday, November 28, 2024, 13:30 Hrs [IST] CPHI & PMEC India 2024 held a ...
Pharmabiz2h
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain: The Woodlands, Texas Thursday, November 28, 2024, 12:00 Hrs [IST ...
Pharmabiz1h
International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats
International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats: Geneva Thursday, November 28, 2024, 13:00 Hrs [IST] The Worl ...
Pharmabiz2h
Biocon Biologics supports Diabetes Africa to drive progress in embedding specialist nurses in Ethiopia
Biocon Biologics supports Diabetes Africa to drive progress in embedding specialist nurses in Ethiopia: Our Bureau, Bengaluru Thursday, November 28, 2024, 11:40 Hrs [IST] Biocon B ...
Pharmabiz1h
CAHO & Orchid Pharma to continue supporting national efforts to check antimicrobial resistance
CAHO & Orchid Pharma to continue supporting national efforts to check antimicrobial resistance: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:30 Hrs [IST] Orchid Pharma an ...
Pharmabiz2h
Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma
Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:15 Hrs [IST] Dr Reddy’s Laboratorie ...
Pharmabiz4h
Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives China NMPA marketing approval for 2L+ advanced or metastatic TNBC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative ...
Pharmabiz3h
VectorBuilde & Sartorius ink strategic cooperation agreement to advance biopharmaceutical innovation
VectorBuilde & Sartorius ink strategic cooperation agreement to advance biopharmaceutical innovation: Chicago, Illinois Thursday, November 28, 2024, 11:00 Hrs [IST] VectorBuilder, ...
Pharmabiz5h
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence: Basel Thursday, November 28, 2024, 09: ...
Pharmabiz6h
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship: Gireesh Babu, New Delhi ...